Brian T. Powl
Chief Commercial Officer at Kura Oncology, Inc. (KURA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $663K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 29SEC | KURAKura Oncology, Inc. | Sell Plan | 9,020160,249 held (−5%) | $10.50 | $95K | +1.0% |
| Sep 29SEC | KURAKura Oncology, Inc. | Sell Plan | 8,000152,249 held (−5%) | $10.56 | $84K | +0.4% |
| Sep 29SEC | KURAKura Oncology, Inc. | Sell Plan | 15,430136,819 held (−10%) | $10.75 | $166K | -1.4% |
| Aug 24SEC | KURAKura Oncology, Inc. | Sell Plan | 4,345169,269 held (−3%) | $11.89 | $52K | -10.8% |
| May 22SEC | KURAKura Oncology, Inc. | Sell Plan | 10,000173,614 held (−5%) | $11.00 | $110K | -3.6% |
| May 20SEC | KURAKura Oncology, Inc. | Sell Plan | 339183,614 held (−0%) | $9.21 | $3K | +15.1% |
| Jan 27SEC | KURAKura Oncology, Inc. | Sell | 4,842184,847 held (−3%) | $8.46 | $41K | +25.3% |
| Jan 27SEC | KURAKura Oncology, Inc. | Sell | 1,572183,275 held (−1%) | $8.46 | $13K | +25.3% |
| Nov 14SEC | KURAKura Oncology, Inc. | Sell | 8,887139,689 held (−6%) | $11.18 | $99K | -5.2% |
- Sell
Chief Commercial Officer Brian T. Powl sold $95K of KURA at $10.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Brian T. Powl sold $84K of KURA at $10.56 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Brian T. Powl sold $166K of KURA at $10.75 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Brian T. Powl sold $52K of KURA at $11.89 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Brian T. Powl sold $110K of KURA at $11.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Brian T. Powl sold $3K of KURA at $9.21 — pre-scheduled 10b5-1 plan sale.